The global market for Monoclonal Antibody Therapeutics was valued at US$ 134470 million in the year 2024 and is projected to reach a revised size of US$ 215900 million by 2031, growing at a CAGR of 7.1% during the forecast period.

Monoclonal Antibody Therapeutics Market

North American market for Monoclonal Antibody Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Monoclonal Antibody Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Monoclonal Antibody Therapeutics in Cancer is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Monoclonal Antibody Therapeutics include Bayer, F. Hoffmann-La Roche, Pfizer, Sanofi, GlaxoSmithKline, Merck, Novartis, AbbVie, Amgen, Johnson & Johnson, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Monoclonal Antibody Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monoclonal Antibody Therapeutics.

The Monoclonal Antibody Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Monoclonal Antibody Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Monoclonal Antibody Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Monoclonal Antibody Therapeutics Market Report

Report Metric	Details
Report Name	Monoclonal Antibody Therapeutics Market
Accounted market size in year	US$ 134470 million
Forecasted market size in 2031	US$ 215900 million
CAGR	7.1%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Humanized Antibody Human Mouse Chimeric Antibody
Segment by Application	Cancer Autoimmune Diseases Infection Hematological Diseases Ophthalmological Diseases Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bayer, F. Hoffmann-La Roche, Pfizer, Sanofi, GlaxoSmithKline, Merck, Novartis, AbbVie, Amgen, Johnson & Johnson, Bristol-Myers Squibb Company, Biogen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Monoclonal Antibody Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Monoclonal Antibody Therapeutics Market growing?

Ans: The Monoclonal Antibody Therapeutics Market witnessing a CAGR of 7.1% during the forecast period 2025-2031.

What is the Monoclonal Antibody Therapeutics Market size in 2031?

Ans: The Monoclonal Antibody Therapeutics Market size in 2031 will be US$ 215900 million.

Who are the main players in the Monoclonal Antibody Therapeutics Market report?

Ans: The main players in the Monoclonal Antibody Therapeutics Market are Bayer, F. Hoffmann-La Roche, Pfizer, Sanofi, GlaxoSmithKline, Merck, Novartis, AbbVie, Amgen, Johnson & Johnson, Bristol-Myers Squibb Company, Biogen

What are the Application segmentation covered in the Monoclonal Antibody Therapeutics Market report?

Ans: The Applications covered in the Monoclonal Antibody Therapeutics Market report are Cancer, Autoimmune Diseases, Infection, Hematological Diseases, Ophthalmological Diseases, Others

What are the Type segmentation covered in the Monoclonal Antibody Therapeutics Market report?

Ans: The Types covered in the Monoclonal Antibody Therapeutics Market report are Humanized Antibody, Human Mouse Chimeric Antibody

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Monoclonal Antibody Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Humanized Antibody

1.2.3 Human Mouse Chimeric Antibody

1.3 Market by Application

1.3.1 Global Monoclonal Antibody Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Cancer

1.3.3 Autoimmune Diseases

1.3.4 Infection

1.3.5 Hematological Diseases

1.3.6 Ophthalmological Diseases

1.3.7 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Monoclonal Antibody Therapeutics Market Perspective (2020-2031)

2.2 Global Monoclonal Antibody Therapeutics Growth Trends by Region

2.2.1 Global Monoclonal Antibody Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Monoclonal Antibody Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Monoclonal Antibody Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Monoclonal Antibody Therapeutics Market Dynamics

2.3.1 Monoclonal Antibody Therapeutics Industry Trends

2.3.2 Monoclonal Antibody Therapeutics Market Drivers

2.3.3 Monoclonal Antibody Therapeutics Market Challenges

2.3.4 Monoclonal Antibody Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Monoclonal Antibody Therapeutics Players by Revenue

3.1.1 Global Top Monoclonal Antibody Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Monoclonal Antibody Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Monoclonal Antibody Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Monoclonal Antibody Therapeutics Revenue

3.4 Global Monoclonal Antibody Therapeutics Market Concentration Ratio

3.4.1 Global Monoclonal Antibody Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Monoclonal Antibody Therapeutics Revenue in 2024

3.5 Global Key Players of Monoclonal Antibody Therapeutics Head office and Area Served

3.6 Global Key Players of Monoclonal Antibody Therapeutics, Product and Application

3.7 Global Key Players of Monoclonal Antibody Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Monoclonal Antibody Therapeutics Breakdown Data by Type

4.1 Global Monoclonal Antibody Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Monoclonal Antibody Therapeutics Forecasted Market Size by Type (2026-2031)

5 Monoclonal Antibody Therapeutics Breakdown Data by Application

5.1 Global Monoclonal Antibody Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Monoclonal Antibody Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Monoclonal Antibody Therapeutics Market Size (2020-2031)

6.2 North America Monoclonal Antibody Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Monoclonal Antibody Therapeutics Market Size by Country (2020-2025)

6.4 North America Monoclonal Antibody Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Monoclonal Antibody Therapeutics Market Size (2020-2031)

7.2 Europe Monoclonal Antibody Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Monoclonal Antibody Therapeutics Market Size by Country (2020-2025)

7.4 Europe Monoclonal Antibody Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Monoclonal Antibody Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Monoclonal Antibody Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Monoclonal Antibody Therapeutics Market Size (2020-2031)

9.2 Latin America Monoclonal Antibody Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Monoclonal Antibody Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Monoclonal Antibody Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Monoclonal Antibody Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Monoclonal Antibody Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Bayer

11.1.1 Bayer Company Details

11.1.2 Bayer Business Overview

11.1.3 Bayer Monoclonal Antibody Therapeutics Introduction

11.1.4 Bayer Revenue in Monoclonal Antibody Therapeutics Business (2020-2025)

11.1.5 Bayer Recent Development

11.2 F. Hoffmann-La Roche

11.2.1 F. Hoffmann-La Roche Company Details

11.2.2 F. Hoffmann-La Roche Business Overview

11.2.3 F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Introduction

11.2.4 F. Hoffmann-La Roche Revenue in Monoclonal Antibody Therapeutics Business (2020-2025)

11.2.5 F. Hoffmann-La Roche Recent Development

11.3 Pfizer

11.3.1 Pfizer Company Details

11.3.2 Pfizer Business Overview

11.3.3 Pfizer Monoclonal Antibody Therapeutics Introduction

11.3.4 Pfizer Revenue in Monoclonal Antibody Therapeutics Business (2020-2025)

11.3.5 Pfizer Recent Development

11.4 Sanofi

11.4.1 Sanofi Company Details

11.4.2 Sanofi Business Overview

11.4.3 Sanofi Monoclonal Antibody Therapeutics Introduction

11.4.4 Sanofi Revenue in Monoclonal Antibody Therapeutics Business (2020-2025)

11.4.5 Sanofi Recent Development

11.5 GlaxoSmithKline

11.5.1 GlaxoSmithKline Company Details

11.5.2 GlaxoSmithKline Business Overview

11.5.3 GlaxoSmithKline Monoclonal Antibody Therapeutics Introduction

11.5.4 GlaxoSmithKline Revenue in Monoclonal Antibody Therapeutics Business (2020-2025)

11.5.5 GlaxoSmithKline Recent Development

11.6 Merck

11.6.1 Merck Company Details

11.6.2 Merck Business Overview

11.6.3 Merck Monoclonal Antibody Therapeutics Introduction

11.6.4 Merck Revenue in Monoclonal Antibody Therapeutics Business (2020-2025)

11.6.5 Merck Recent Development

11.7 Novartis

11.7.1 Novartis Company Details

11.7.2 Novartis Business Overview

11.7.3 Novartis Monoclonal Antibody Therapeutics Introduction

11.7.4 Novartis Revenue in Monoclonal Antibody Therapeutics Business (2020-2025)

11.7.5 Novartis Recent Development

11.8 AbbVie

11.8.1 AbbVie Company Details

11.8.2 AbbVie Business Overview

11.8.3 AbbVie Monoclonal Antibody Therapeutics Introduction

11.8.4 AbbVie Revenue in Monoclonal Antibody Therapeutics Business (2020-2025)

11.8.5 AbbVie Recent Development

11.9 Amgen

11.9.1 Amgen Company Details

11.9.2 Amgen Business Overview

11.9.3 Amgen Monoclonal Antibody Therapeutics Introduction

11.9.4 Amgen Revenue in Monoclonal Antibody Therapeutics Business (2020-2025)

11.9.5 Amgen Recent Development

11.10 Johnson & Johnson

11.10.1 Johnson & Johnson Company Details

11.10.2 Johnson & Johnson Business Overview

11.10.3 Johnson & Johnson Monoclonal Antibody Therapeutics Introduction

11.10.4 Johnson & Johnson Revenue in Monoclonal Antibody Therapeutics Business (2020-2025)

11.10.5 Johnson & Johnson Recent Development

11.11 Bristol-Myers Squibb Company

11.11.1 Bristol-Myers Squibb Company Company Details

11.11.2 Bristol-Myers Squibb Company Business Overview

11.11.3 Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Introduction

11.11.4 Bristol-Myers Squibb Company Revenue in Monoclonal Antibody Therapeutics Business (2020-2025)

11.11.5 Bristol-Myers Squibb Company Recent Development

11.12 Biogen

11.12.1 Biogen Company Details

11.12.2 Biogen Business Overview

11.12.3 Biogen Monoclonal Antibody Therapeutics Introduction

11.12.4 Biogen Revenue in Monoclonal Antibody Therapeutics Business (2020-2025)

11.12.5 Biogen Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Bristol Myers Squibb Company

Biogen

List of Tables

Table 1. Global Monoclonal Antibody Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Humanized Antibody

Table 3. Key Players of Human Mouse Chimeric Antibody

Table 4. Global Monoclonal Antibody Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Monoclonal Antibody Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Monoclonal Antibody Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Monoclonal Antibody Therapeutics Market Share by Region (2020-2025)

Table 8. Global Monoclonal Antibody Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Monoclonal Antibody Therapeutics Market Share by Region (2026-2031)

Table 10. Monoclonal Antibody Therapeutics Market Trends

Table 11. Monoclonal Antibody Therapeutics Market Drivers

Table 12. Monoclonal Antibody Therapeutics Market Challenges

Table 13. Monoclonal Antibody Therapeutics Market Restraints

Table 14. Global Monoclonal Antibody Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Monoclonal Antibody Therapeutics Market Share by Players (2020-2025)

Table 16. Global Top Monoclonal Antibody Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Therapeutics as of 2024)

Table 17. Ranking of Global Top Monoclonal Antibody Therapeutics Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Monoclonal Antibody Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Monoclonal Antibody Therapeutics, Headquarters and Area Served

Table 20. Global Key Players of Monoclonal Antibody Therapeutics, Product and Application

Table 21. Global Key Players of Monoclonal Antibody Therapeutics, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Monoclonal Antibody Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Monoclonal Antibody Therapeutics Revenue Market Share by Type (2020-2025)

Table 25. Global Monoclonal Antibody Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Monoclonal Antibody Therapeutics Revenue Market Share by Type (2026-2031)

Table 27. Global Monoclonal Antibody Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Monoclonal Antibody Therapeutics Revenue Market Share by Application (2020-2025)

Table 29. Global Monoclonal Antibody Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Monoclonal Antibody Therapeutics Revenue Market Share by Application (2026-2031)

Table 31. North America Monoclonal Antibody Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Monoclonal Antibody Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Monoclonal Antibody Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Monoclonal Antibody Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Monoclonal Antibody Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Monoclonal Antibody Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Monoclonal Antibody Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Monoclonal Antibody Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Monoclonal Antibody Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Monoclonal Antibody Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Monoclonal Antibody Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 46. Bayer Company Details

Table 47. Bayer Business Overview

Table 48. Bayer Monoclonal Antibody Therapeutics Product

Table 49. Bayer Revenue in Monoclonal Antibody Therapeutics Business (2020-2025) & (US$ Million)

Table 50. Bayer Recent Development

Table 51. F. Hoffmann-La Roche Company Details

Table 52. F. Hoffmann-La Roche Business Overview

Table 53. F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Product

Table 54. F. Hoffmann-La Roche Revenue in Monoclonal Antibody Therapeutics Business (2020-2025) & (US$ Million)

Table 55. F. Hoffmann-La Roche Recent Development

Table 56. Pfizer Company Details

Table 57. Pfizer Business Overview

Table 58. Pfizer Monoclonal Antibody Therapeutics Product

Table 59. Pfizer Revenue in Monoclonal Antibody Therapeutics Business (2020-2025) & (US$ Million)

Table 60. Pfizer Recent Development

Table 61. Sanofi Company Details

Table 62. Sanofi Business Overview

Table 63. Sanofi Monoclonal Antibody Therapeutics Product

Table 64. Sanofi Revenue in Monoclonal Antibody Therapeutics Business (2020-2025) & (US$ Million)

Table 65. Sanofi Recent Development

Table 66. GlaxoSmithKline Company Details

Table 67. GlaxoSmithKline Business Overview

Table 68. GlaxoSmithKline Monoclonal Antibody Therapeutics Product

Table 69. GlaxoSmithKline Revenue in Monoclonal Antibody Therapeutics Business (2020-2025) & (US$ Million)

Table 70. GlaxoSmithKline Recent Development

Table 71. Merck Company Details

Table 72. Merck Business Overview

Table 73. Merck Monoclonal Antibody Therapeutics Product

Table 74. Merck Revenue in Monoclonal Antibody Therapeutics Business (2020-2025) & (US$ Million)

Table 75. Merck Recent Development

Table 76. Novartis Company Details

Table 77. Novartis Business Overview

Table 78. Novartis Monoclonal Antibody Therapeutics Product

Table 79. Novartis Revenue in Monoclonal Antibody Therapeutics Business (2020-2025) & (US$ Million)

Table 80. Novartis Recent Development

Table 81. AbbVie Company Details

Table 82. AbbVie Business Overview

Table 83. AbbVie Monoclonal Antibody Therapeutics Product

Table 84. AbbVie Revenue in Monoclonal Antibody Therapeutics Business (2020-2025) & (US$ Million)

Table 85. AbbVie Recent Development

Table 86. Amgen Company Details

Table 87. Amgen Business Overview

Table 88. Amgen Monoclonal Antibody Therapeutics Product

Table 89. Amgen Revenue in Monoclonal Antibody Therapeutics Business (2020-2025) & (US$ Million)

Table 90. Amgen Recent Development

Table 91. Johnson & Johnson Company Details

Table 92. Johnson & Johnson Business Overview

Table 93. Johnson & Johnson Monoclonal Antibody Therapeutics Product

Table 94. Johnson & Johnson Revenue in Monoclonal Antibody Therapeutics Business (2020-2025) & (US$ Million)

Table 95. Johnson & Johnson Recent Development

Table 96. Bristol-Myers Squibb Company Company Details

Table 97. Bristol-Myers Squibb Company Business Overview

Table 98. Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Product

Table 99. Bristol-Myers Squibb Company Revenue in Monoclonal Antibody Therapeutics Business (2020-2025) & (US$ Million)

Table 100. Bristol-Myers Squibb Company Recent Development

Table 101. Biogen Company Details

Table 102. Biogen Business Overview

Table 103. Biogen Monoclonal Antibody Therapeutics Product

Table 104. Biogen Revenue in Monoclonal Antibody Therapeutics Business (2020-2025) & (US$ Million)

Table 105. Biogen Recent Development

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

Table 109. Authors List of This Report

List of Figures

Figure 1. Monoclonal Antibody Therapeutics Picture

Figure 2. Global Monoclonal Antibody Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Monoclonal Antibody Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. Humanized Antibody Features

Figure 5. Human Mouse Chimeric Antibody Features

Figure 6. Global Monoclonal Antibody Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Monoclonal Antibody Therapeutics Market Share by Application: 2024 VS 2031

Figure 8. Cancer Case Studies

Figure 9. Autoimmune Diseases Case Studies

Figure 10. Infection Case Studies

Figure 11. Hematological Diseases Case Studies

Figure 12. Ophthalmological Diseases Case Studies

Figure 13. Others Case Studies

Figure 14. Monoclonal Antibody Therapeutics Report Years Considered

Figure 15. Global Monoclonal Antibody Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Monoclonal Antibody Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Monoclonal Antibody Therapeutics Market Share by Region: 2024 VS 2031

Figure 18. Global Monoclonal Antibody Therapeutics Market Share by Players in 2024

Figure 19. Global Top Monoclonal Antibody Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Therapeutics as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Monoclonal Antibody Therapeutics Revenue in 2024

Figure 21. North America Monoclonal Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Monoclonal Antibody Therapeutics Market Share by Country (2020-2031)

Figure 23. United States Monoclonal Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Monoclonal Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Monoclonal Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Monoclonal Antibody Therapeutics Market Share by Country (2020-2031)

Figure 27. Germany Monoclonal Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Monoclonal Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Monoclonal Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Monoclonal Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Monoclonal Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Monoclonal Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Monoclonal Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Monoclonal Antibody Therapeutics Market Share by Region (2020-2031)

Figure 35. China Monoclonal Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Monoclonal Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Monoclonal Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Monoclonal Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Monoclonal Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Monoclonal Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Monoclonal Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Monoclonal Antibody Therapeutics Market Share by Country (2020-2031)

Figure 43. Mexico Monoclonal Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Monoclonal Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Monoclonal Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Monoclonal Antibody Therapeutics Market Share by Country (2020-2031)

Figure 47. Turkey Monoclonal Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Monoclonal Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Monoclonal Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Bayer Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2020-2025)

Figure 51. F. Hoffmann-La Roche Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2020-2025)

Figure 52. Pfizer Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2020-2025)

Figure 53. Sanofi Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2020-2025)

Figure 54. GlaxoSmithKline Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2020-2025)

Figure 55. Merck Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2020-2025)

Figure 56. Novartis Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2020-2025)

Figure 57. AbbVie Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2020-2025)

Figure 58. Amgen Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2020-2025)

Figure 59. Johnson & Johnson Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2020-2025)

Figure 60. Bristol-Myers Squibb Company Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2020-2025)

Figure 61. Biogen Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-19G16926

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global ELISA Immunoassay Plates Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-7Z17064

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Ready-to-Use ELISA Kits Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-20P20045

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Moxidectin Injection Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3Z19977

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Monoclonal Antibody Therapeutics Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-39Q16036

Global Monoclonal Antibody Therapeutics Market Research Report 2025

FEATURED COMPANIES

Monoclonal Antibody Therapeutics Market Size

Monoclonal Antibody Therapeutics Market

Scope of Monoclonal Antibody Therapeutics Market Report

Chapter Outline

FAQ for this report

How fast is Monoclonal Antibody Therapeutics Market growing?

What is the Monoclonal Antibody Therapeutics Market size in 2031?

Who are the main players in the Monoclonal Antibody Therapeutics Market report?

What are the Application segmentation covered in the Monoclonal Antibody Therapeutics Market report?

What are the Type segmentation covered in the Monoclonal Antibody Therapeutics Market report?

FEATURED COMPANIES

RELATED REPORTS